Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Weatherly, Helen
Drummond, Michael
Claxton, Karl
Cookson, Richard
Ferguson, Brian
Godfrey, Christine
Rice, Nigel
Sculpher, Mark
and
Sowden, Amanda
2009.
Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations.
Health Policy,
Vol. 93,
Issue. 2-3,
p.
85.
Lorgelly, Paula K.
Lawson, Kenny D.
Fenwick, Elisabeth A.L.
and
Briggs, Andrew H.
2010.
Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach?.
International Journal of Environmental Research and Public Health,
Vol. 7,
Issue. 5,
p.
2274.
Shemilt, Ian
Mugford, Miranda
Vale, Luke
Marsh, Kevin
Donaldson, Cam
and
Drummond, Michael
2010.
Evidence synthesis, economics and public policy.
Research Synthesis Methods,
Vol. 1,
Issue. 2,
p.
126.
Green, Colin
2010.
Considering the value associated with innovation in health technology appraisal decisions (deliberations).
Applied Health Economics and Health Policy,
Vol. 8,
Issue. 1,
p.
1.
McDaid, David
and
Sassi, Franco
2010.
Evidence‐Based Decisions and Economics.
p.
67.
Whitehead, S. J.
and
Ali, S.
2010.
Health outcomes in economic evaluation: the QALY and utilities.
British Medical Bulletin,
Vol. 96,
Issue. 1,
p.
5.
Johri, Mira
and
Norheim, Ole Frithjof
2012.
CAN COST-EFFECTIVENESS ANALYSIS INTEGRATE CONCERNS FOR EQUITY? SYSTEMATIC REVIEW.
International Journal of Technology Assessment in Health Care,
Vol. 28,
Issue. 2,
p.
125.
Hughes, David
2012.
Le rationnement équitable des médicaments onéreux au Québec - les critères d’évaluation et principes éthiques.
Éthique publique,
Singh, Jeshika
Lord, Joanne
Longworth, Louise
Orr, Shepley
McGarry, Teresa
Sheldon, Rob
and
Buxton, Martin
2012.
Does Responsibility Affect the Public's Valuation of Health Care Interventions? A Relative Valuation Approach to Health Care Safety.
Value in Health,
Vol. 15,
Issue. 5,
p.
690.
Soares, M. O.
2012.
Is the QALY blind, deaf and dumb to equity? NICE's considerations over equity.
British Medical Bulletin,
Vol. 101,
Issue. 1,
p.
17.
Bobinac, Ana
van Exel, N. Job A.
Rutten, Frans F.H.
and
Brouwer, Werner B.F.
2012.
Inquiry into the Relationship between Equity Weights and the Value of the QALY.
Value in Health,
Vol. 15,
Issue. 8,
p.
1119.
Culyer, Anthony J.
and
Bombard, Yvonne
2012.
An Equity Framework for Health Technology Assessments.
Medical Decision Making,
Vol. 32,
Issue. 3,
p.
428.
Trueman, P.
and
Anokye, N. K.
2013.
Applying economic evaluation to public health interventions: the case of interventions to promote physical activity.
Journal of Public Health,
Vol. 35,
Issue. 1,
p.
32.
Thomopoulos, Nikolaos
and
Grant-Muller, Susan
2013.
Incorporating equity as part of the wider impacts in transport infrastructure assessment: an application of the SUMINI approach.
Transportation,
Vol. 40,
Issue. 2,
p.
315.
Quinn, Emma
Mitton, Craig
and
Ward, Jeanette
2013.
Knowledge Translation in Health Care.
p.
349.
Chicaíza, Liliana
García Molina, Mario
and
Romano, Giancarlo
2013.
Años de vida ajustados por calidad: evolución, fundamentos e implicaciones (Quality Adjusted Life Years: Evolution, Fundamentals and Implications).
SSRN Electronic Journal,
van de Wetering, E. J.
Stolk, E. A.
van Exel, N. J. A.
and
Brouwer, W. B. F.
2013.
Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall.
The European Journal of Health Economics,
Vol. 14,
Issue. 1,
p.
107.
Singh, Jeshika
Longworth, Louise
Baine, Amanda
Lord, Joanne
Orr, Shepley
and
Buxton, Martin
2013.
Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choices.
BMC Health Services Research,
Vol. 13,
Issue. 1,
Marks, L.
Weatherly, H.
and
Mason, A.
2013.
Prioritizing investment in public health and health equity: what can commissioners do?.
Public Health,
Vol. 127,
Issue. 5,
p.
410.
Metcalfe, Scott
Grocott, Rachel
and
Rasiah, Dilky
2014.
Comment on “Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following its 20th Anniversary”.
PharmacoEconomics,
Vol. 32,
Issue. 10,
p.
1031.